|Bid||84.40 x 1300|
|Ask||84.58 x 900|
|Day's Range||83.57 - 85.44|
|52 Week Range||55.36 - 90.61|
|Beta (5Y Monthly)||0.82|
|PE Ratio (TTM)||15.48|
|Earnings Date||Nov 04, 2021 - Nov 08, 2021|
|Forward Dividend & Yield||2.00 (2.34%)|
|Ex-Dividend Date||Jul 22, 2021|
|1y Target Est||96.11|
In the latest trading session, CVS Health (CVS) closed at $84.58, marking a -1.09% move from the previous day.
CVS Health (NYSE: CVS), one of the biggest U.S. providers of COVID-19 tests and vaccines, plans to hire 25,000 people this week, if it can, to address staffing shortages that have seen some customers seeking shots turned away, says this Wall Street Journal piece [subscription required]. The Millionacres takeaway: The nation's biggest drugstore chain is a mainstay in many a commercial real estate portfolio, so foot traffic there is good from that perspective.
CVS Health on Monday said it planned to hire 25,000 clinical and retail employees to prepare for a potential surge in demand during the flu season as coronavirus-related vaccine shots and testing continue to rise. "Every flu season we need additional team members, but this year we're looking for even more," Neela Montgomery, president of CVS Pharmacy and executive vice president of the parent, said in a statement. "With the continued presence of Covid-19 in our communities, we're estimating a much greater need for pharmacists, trained pharmacy technicians, nurses, and retail store associates," Montgomery said.